CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...
Phase 2
San Antonio, Texas, United States and 44 other locations
and safety of 1 dose level of 2-hydroxypropyl-β-cyclodextrin (2-HPβCD) given intravenously in adult patients with type 2 diabetes with diabetic kidney...
Phase 2
San Antonio, Texas, United States
of intravenous Gemini in adult subjects with stage 3 or 4 chronic kidney disease. Pharmacokinetics will be evaluated and measuremen...
Phase 1, Phase 2
San Antonio, Texas, United States and 2 other locations
This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific t ...
Phase 2
San Antonio, Texas, United States and 129 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
San Antonio, Texas, United States and 295 other locations
safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney...
Phase 1
San Antonio, Texas, United States and 11 other locations
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney...
Phase 2
San Antonio, Texas, United States and 118 other locations
CRP-lowering effect of quarterly and monthly subcutaneous administration of TOUR006 (also known as pacibekitug) in participants with chronic kidney...
Phase 2
San Antonio, Texas, United States and 48 other locations
to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous cat...
Phase 1, Phase 2
San Antonio, Texas, United States and 19 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
San Antonio, Texas, United States and 338 other locations
Clinical trials
Research sites
Resources
Legal